Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery
Evaluation of Clinical Effectiveness and Safety of Tarvos Microguidewire in Neurovascular Interventional Surgery
1 other identifier
observational
121
1 country
1
Brief Summary
This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedFirst Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedApril 2, 2026
March 1, 2026
2 months
March 24, 2026
March 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Device success rate
Number of patients with device success / Number of recruited patients\* 100%
during surgery
Secondary Outcomes (1)
Ability to assist in the delivery of other interventional devices to the targeted vessel position.
during surgery
Other Outcomes (1)
Incidence of adverse events, serious adverse events and device deficiencies
within postoperative 24 hrs
Study Arms (1)
single arm
Interventions
This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site.
Eligibility Criteria
Undertaken a neurovascular surgery procedure including Tarvos Microguidewire
You may qualify if:
- Undertaken a neurovascular surgery procedure including Tarvos microguidewire
- Available images of Tarvos Microguidewire in the neurovascular surgery.
You may not qualify if:
- Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome)
- Prior vascular dissection or injury to the target vessels
- Not meeting the data requirements needed for this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Keuro MedTechlead
Study Sites (1)
Xingtai central hospital
Xingtai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2026
First Posted
March 30, 2026
Study Start
January 29, 2026
Primary Completion
March 15, 2026
Study Completion
March 15, 2026
Last Updated
April 2, 2026
Record last verified: 2026-03